Literature DB >> 17346538

Accuracy of preoperative endometrial sampling for the detection of high-grade endometrial tumors.

Gloria S Huang1, Juliana S Gebb, Mark H Einstein, Shohreh Shahabi, Akiva P Novetsky, Gary L Goldberg.   

Abstract

OBJECTIVE: This study was undertaken to evaluate the ability of preoperative endometrial sampling to accurately diagnose high-grade endometrial tumors. STUDY
DESIGN: Three hundred sixty endometrial cancer patients had preoperative endometrial sampling and hysterectomy specimens that underwent pathologic review at a single institution from 1995 to 2005. The sensitivity of Pipelle and curettage to diagnose high-grade endometrial tumors (grade 3 endometrioid adenocarcinoma, serous carcinoma, carcinosarcoma, clear cell carcinoma) was determined. Agreement between preoperative and hysterectomy diagnoses was measured by the Kappa statistic.
RESULTS: Sensitivity of Pipelle and curettage was 93.8% and 97% in patients with low-grade cancer and 99.2% and 100% in patients with high-grade cancer. Good agreement was observed between the preoperative and the hysterectomy histologic diagnoses (Kappa = 0.69), and between the preoperative and hysterectomy tumor grade (Kappa=0.78).
CONCLUSION: Preoperative endometrial sampling with Pipelle or curettage is sensitive and accurate for the diagnosis of high-grade endometrial tumors, including tumors with nonendometrioid histology.

Entities:  

Mesh:

Year:  2007        PMID: 17346538     DOI: 10.1016/j.ajog.2006.09.035

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  25 in total

1.  Serum CA125 predicts extrauterine disease and survival in uterine carcinosarcoma.

Authors:  Gloria S Huang; Lydia G Chiu; Juliana S Gebb; Marc J Gunter; Paniti Sukumvanich; Gary L Goldberg; Mark H Einstein
Journal:  Gynecol Oncol       Date:  2007-10-23       Impact factor: 5.482

2.  Excellent Response to Palliative Chemotherapy for Pleural Recurrence of Uterine Papillary Serous Carcinoma.

Authors:  Shantanu Singh; David Mack; Dianne Dookhan; Juthika Jyotimallika
Journal:  World J Oncol       Date:  2013-09-27

3.  Vascular marker expression during the development of various types of gynaecological malignancy.

Authors:  Peter Urban; Miroslava Bilecova Rabajdova; Jan Varga; Peter Kruzliak; Viera Fialkovicova; Eva Durovcova; Maria Marekova
Journal:  Tumour Biol       Date:  2014-08-12

4.  Accuracy of pre-operative hysteroscopic guided biopsy for predicting final pathology in uterine malignancies.

Authors:  Fabio Martinelli; Antonino Ditto; Giorgio Bogani; Mauro Signorelli; Valentina Chiappa; Domenica Lorusso; Edward Haeusler; Francesco Raspagliesi
Journal:  J Cancer Res Clin Oncol       Date:  2017-03-01       Impact factor: 4.553

5.  Role of spiral artery Doppler to screen type 2 endometrial cancer cases.

Authors:  Soner Düzgüner; Mehmet Burak Ozkan; Tuncay Küçüközkan; Enis Ozkaya; Fadıl Kara; Ipek Nur Balın; Vakkas Korkmaz; Mehmet Fatih Karslı; Burak Gültekin
Journal:  J Turk Ger Gynecol Assoc       Date:  2014-03-01

6.  Pipelle endometrial sampling versus conventional dilatation & curettage in patients with abnormal uterine bleeding.

Authors:  Ibrahim Anwar Abdelazim; Amro Aboelezz; Amr Fathy Abdulkareem
Journal:  J Turk Ger Gynecol Assoc       Date:  2013-03-01

7.  Laparoscopic supracervical hysterectomy with morcellation: should it stay or should it go?

Authors:  Jubilee Brown; Kristal Taylor; Pedro T Ramirez; Charlotte Sun; Laura L Holman; S Mark Cone; John Irwin; Michael Frumovitz
Journal:  J Minim Invasive Gynecol       Date:  2014-09-19       Impact factor: 4.137

8.  Progestin therapy of complex endometrial hyperplasia with and without atypia.

Authors:  Susan D Reed; Linda F Voigt; Katherine M Newton; Rochelle H Garcia; H Kimberly Allison; Meira Epplein; Diana Jordan; Elizabeth Swisher; Noel S Weiss
Journal:  Obstet Gynecol       Date:  2009-03       Impact factor: 7.661

9.  Concordance between preoperative ESMO-ESGO-ESTRO risk classification and final histology in early-stage endometrial cancer.

Authors:  Manon Daix; Martina Aida Angeles; Federico Migliorelli; Athanasios Kakkos; Carlos Martinez Gomez; Katty Delbecque; Eliane Mery; Stéphanie Tock; Erwan Gabiache; Marjolein Decuypere; Frédéric Goffin; Alejandra Martinez; Gwénaël Ferron; Frédéric Kridelka
Journal:  J Gynecol Oncol       Date:  2021-04-05       Impact factor: 4.401

10.  PIpelle Prospective ENDOmetrial carcinoma (PIPENDO) study, pre-operative recognition of high risk endometrial carcinoma: a multicentre prospective cohort study.

Authors:  Nicole C M Visser; Johan Bulten; Anneke A M van der Wurff; Erik A Boss; Carolien M Bronkhorst; Harrie W H Feijen; Joke E Haartsen; Hilde A D M van Herk; Ineke M de Kievit; Paul J J M Klinkhamer; Brenda M Pijlman; Marc P M L Snijders; Ingrid Vandenput; M Caroline Vos; Peter E J de Wit; Lonneke V van de Poll-Franse; Leon F A G Massuger; Johanna M A Pijnenborg
Journal:  BMC Cancer       Date:  2015-06-30       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.